SELLAS Life Sciences Group, Inc.
Balance Sheet
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Equivalents | $2.3M | $6.0M | $1.4M | $23.7M | $47.8M | $32.8M | $47.8M | $6.9M |
| Accounts Receivable | — | — | — | $1.8M | $3.7M | $0 | — | — |
| Inventory | — | — | $0 | $655.0K | $386.0K | $0 | — | — |
| Total Current Assets | $13.1M | $6.4M | $53.6M | $52.1M | $53.5M | $36.1M | $11.8M | $7.0M |
| Property, Plant & Equipment | — | $199.0K | $335.0K | $285.0K | $665.0K | $29.0K | $393.0K | $419.0K |
| Goodwill | $1.9M | $5.9M | $5.9M | $5.9M | $5.9M | $5.9M | $5.9M | $0 |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — | — |
| Total Assets | $33.5M | $6.4M | $82.1M | $80.5M | $88.0M | $55.0M | $31.0M | $7.5M |
| Liabilities | ||||||||
| Accounts Payable | $11.7M | $840.0K | $1.6M | $1.9M | $2.7M | $2.0M | $2.2M | $724.0K |
| Total Current Liabilities | $24.6M | $5.8M | $57.1M | $27.2M | $62.5M | $15.9M | $11.2M | $5.0M |
| Long-Term Debt | $2.6M | — | $0 | $4.5M | $7.7M | $0 | — | — |
| Total Liabilities | $31.5M | $11.4M | $68.6M | $43.4M | $82.1M | $27.2M | $20.9M | $5.0M |
| Stockholders' Equity | ||||||||
| Retained Earnings | $-54.2M | $-30.4M | — | — | — | — | — | — |
| Total Stockholders' Equity | $2.1M | $-5.0M | $-12.3M | $37.1M | $5.9M | $27.8M | $10.1M | $2.4M |